Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zontron pharmaceuticals sdn. bhd. - ascorbic acid; folic acid; ferrous fumarate; cyanocobalamin; pyridoxine hcl/vitamin b6 -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - misoprostol, quantity: 200 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; hydrogenated castor oil; microcrystalline cellulose; hypromellose - cytotec is indicated in the treatment of acute duodenal and gastric ulcers. cytotec is indicated for the prevention of stress-induced upper gastrointestinal mucosal bleeding and lesions in post-surgical patients in intensive care units. cytotec is indicated for the prevention of gastric ulceration in patients in whom nsaid therapy is essential and who have been assessed at high risk of gastric ulceration, or the complications of gastric ulceration.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; indigo carmine; quinoline yellow; iron oxide yellow; iron oxide red; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famotidine, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: purified talc; hyprolose; iron oxide yellow; ethanol absolute; purified water; diacetylated monoglycerides; magnesium stearate; light magnesium oxide; hypromellose phthalate; ethylcellulose; titanium dioxide; carnauba wax; mannitol - ? treatment and prevention of relapse of gastro-oesophageal reflux disease,? symptomatic treatment of gastro-oesophageal reflux disease,? treatment of duodenal ulcers,? treatment of gastric ulcers.,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal antiinflammatory,drugs (nsaids) usually require treatment with antimicrobial agents in addition to,antisecretory drugs whether on first presentation or on recurrence.,it is also indicated, in combination with clarithromycin and amoxycillin, for,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: hyprolose; magnesium stearate; diacetylated monoglycerides; purified talc; ethylcellulose; mannitol; titanium dioxide; light magnesium oxide; carnauba wax; purified water; ethanol absolute; iron oxide red; hypromellose phthalate - ? treatment and prevention of relapse of gastro-oesophageal reflux disease,? symptomatic treatment of gastro-oesophageal reflux disease,? treatment of duodenal ulcers,? treatment of gastric ulcers.,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal antiinflammatory,drugs (nsaids) usually require treatment with antimicrobial agents in addition to,antisecretory drugs whether on first presentation or on recurrence.,it is also indicated, in combination with clarithromycin and amoxycillin, for,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); mannitol; sodium lauryl sulfate; ethylcellulose; polysorbate 80; magnesium stearate; hyprolose; purified talc; iron oxide yellow; povidone; light magnesium oxide; propylene glycol; titanium dioxide - rabeprazole is indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - (tablet core, product) drospirenone; (tablet core, product) ethinylestradiol betadex clathrate - tablet, film coated - 3.000 mg - (tablet core, product) drospirenone 3.000 mg; (tablet core, product) ethinylestradiol betadex clathrate 0.020 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; indigo carmine; quinoline yellow; iron oxide yellow; iron oxide red; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - famotidine, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.